Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (711-720 of 1,058) with videos related to

Pageof 106
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disordersThomas S Lin, Kristie A Blum, Diane Beth Fischer, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
Blood|March 11, 2008
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selectionEmanuela M Ghia, Sonia Jain, George F Widhopf, et al.
Blood Cancer Journal|February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE studyM Montillo, S O'Brien, A Tedeschi, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Leukemia|July 4, 2014
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib responseW E Pierceall, S L Warner, R J Lena, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I studyCharles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Nature|April 24, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1Puneet Agarwal, Avery Sampson, Kathleen Hueneman, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
Pageof 106

Showing results (711-720 of 1,058) with videos related to

Sort By:
Pageof 106
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disordersThomas S Lin, Kristie A Blum, Diane Beth Fischer, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
Blood|March 11, 2008
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selectionEmanuela M Ghia, Sonia Jain, George F Widhopf, et al.
Blood Cancer Journal|February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE studyM Montillo, S O'Brien, A Tedeschi, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Leukemia|July 4, 2014
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib responseW E Pierceall, S L Warner, R J Lena, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I studyCharles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Nature|April 24, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1Puneet Agarwal, Avery Sampson, Kathleen Hueneman, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
Pageof 106